0.017640
0.000000
0.000000
0.000000
0.015870
0.000000
0.000000
0.000000
0.017062
0.000000
0.000000
0.000000
Zhang, X.
Schwartz, J.D.
Almo, S.C.
Nathenson, S.G.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
8
90.00
90.00
90.00
56.690
63.010
58.610
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Proc.Natl.Acad.Sci.USA
PNASA6
0040
0027-8424
100
2586
2591
10.1073/pnas.252771499
12606712
Crystal Structure of the Receptor-Binding Domain of Human B7-2: Insights into Organization and Signaling
2003
US
Protein Expr.Purif.
PEXPEJ
0757
1046-5928
25
105
113
10.1006/prep.2002.1616
Expression, Refolding, Purification, Molecular Characterization, Crystallization, and Preliminary X-ray Analysis of the Receptor Binding Domain of Human B7-2
2002
100
1
CCD
1999-01-01
ADSC QUANTUM 4
MAD
M
x-ray
1
0.96110
1.0
0.98000
1.0
0.98019
1.0
X9B
NSLS
0.96110, 0.98000, 0.98019
SYNCHROTRON
NSLS BEAMLINE X9B
12849.631
T lymphocyte activation antigen CD86
Ig V-type domain
2
man
polymer
B7-2, Activation B7-2 antigen, CTLA-4 counter-receptor B7.2, B70, FUN-1, BU63
no
no
MLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKD
KGLYQCIIHHKKPTGMIRIHQMNSELSVLA
MLKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKD
KGLYQCIIHHKKPTGMIRIHQMNSELSVLA
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
sample
B7-2
9606
Homo sapiens
562
Escherichia coli
BL21(DE3), B834(DE3)
plasmid
pET3a
1
2.07
40.18
VAPOR DIFFUSION, HANGING DROP
8.5
PEG4000, NaAC, Tris-HCl, pH 8.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
277
repository
Initial release
Version format compliance
Version format compliance
1
0
2003-03-11
1
1
2008-04-28
1
2
2011-07-13
the complex between the receptor-binding domain of human B7-2 and dimeric CTLA-4
RCSB
Y
RCSB
2002-12-05
REL
REL
MET
0
n
1
MET
0
A
LEU
1
n
2
LEU
1
A
LYS
2
n
3
LYS
2
A
ILE
3
n
4
ILE
3
A
GLN
4
n
5
GLN
4
A
ALA
5
n
6
ALA
5
A
TYR
6
n
7
TYR
6
A
PHE
7
n
8
PHE
7
A
ASN
8
n
9
ASN
8
A
GLU
9
n
10
GLU
9
A
THR
10
n
11
THR
10
A
ALA
11
n
12
ALA
11
A
ASP
12
n
13
ASP
12
A
LEU
13
n
14
LEU
13
A
PRO
14
n
15
PRO
14
A
CYS
15
n
16
CYS
15
A
GLN
16
n
17
GLN
16
A
PHE
17
n
18
PHE
17
A
ALA
18
n
19
ALA
18
A
ASN
19
n
20
ASN
19
A
SER
20
n
21
SER
20
A
GLN
21
n
22
GLN
21
A
ASN
22
n
23
ASN
22
A
GLN
23
n
24
GLN
23
A
SER
24
n
25
SER
24
A
LEU
25
n
26
LEU
25
A
SER
26
n
27
SER
26
A
GLU
27
n
28
GLU
27
A
LEU
28
n
29
LEU
28
A
VAL
29
n
30
VAL
29
A
VAL
30
n
31
VAL
30
A
PHE
31
n
32
PHE
31
A
TRP
32
n
33
TRP
32
A
GLN
33
n
34
GLN
33
A
ASP
34
n
35
ASP
34
A
GLN
35
n
36
GLN
35
A
GLU
36
n
37
GLU
36
A
ASN
37
n
38
ASN
37
A
LEU
38
n
39
LEU
38
A
VAL
39
n
40
VAL
39
A
LEU
40
n
41
LEU
40
A
ASN
41
n
42
ASN
41
A
GLU
42
n
43
GLU
42
A
VAL
43
n
44
VAL
43
A
TYR
44
n
45
TYR
44
A
LEU
45
n
46
LEU
45
A
GLY
46
n
47
GLY
46
A
LYS
47
n
48
LYS
47
A
GLU
48
n
49
GLU
48
A
LYS
49
n
50
LYS
49
A
PHE
50
n
51
PHE
50
A
ASP
51
n
52
ASP
51
A
SER
52
n
53
SER
52
A
VAL
53
n
54
VAL
53
A
HIS
54
n
55
HIS
54
A
SER
55
n
56
SER
55
A
LYS
56
n
57
LYS
56
A
TYR
57
n
58
TYR
57
A
MET
58
n
59
MET
58
A
GLY
59
n
60
GLY
59
A
ARG
60
n
61
ARG
60
A
THR
61
n
62
THR
61
A
SER
62
n
63
SER
62
A
PHE
63
n
64
PHE
63
A
ASP
64
n
65
ASP
64
A
SER
65
n
66
SER
65
A
ASP
66
n
67
ASP
66
A
SER
67
n
68
SER
67
A
TRP
68
n
69
TRP
68
A
THR
69
n
70
THR
69
A
LEU
70
n
71
LEU
70
A
ARG
71
n
72
ARG
71
A
LEU
72
n
73
LEU
72
A
HIS
73
n
74
HIS
73
A
ASN
74
n
75
ASN
74
A
LEU
75
n
76
LEU
75
A
GLN
76
n
77
GLN
76
A
ILE
77
n
78
ILE
77
A
LYS
78
n
79
LYS
78
A
ASP
79
n
80
ASP
79
A
LYS
80
n
81
LYS
80
A
GLY
81
n
82
GLY
81
A
LEU
82
n
83
LEU
82
A
TYR
83
n
84
TYR
83
A
GLN
84
n
85
GLN
84
A
CYS
85
n
86
CYS
85
A
ILE
86
n
87
ILE
86
A
ILE
87
n
88
ILE
87
A
HIS
88
n
89
HIS
88
A
HIS
89
n
90
HIS
89
A
LYS
90
n
91
LYS
90
A
LYS
91
n
92
LYS
91
A
PRO
92
n
93
PRO
92
A
THR
93
n
94
THR
93
A
GLY
94
n
95
GLY
94
A
MET
95
n
96
MET
95
A
ILE
96
n
97
ILE
96
A
ARG
97
n
98
ARG
97
A
ILE
98
n
99
ILE
98
A
HIS
99
n
100
HIS
99
A
GLN
100
n
101
GLN
100
A
MET
101
n
102
MET
101
A
ASN
102
n
103
ASN
102
A
SER
103
n
104
SER
103
A
GLU
104
n
105
GLU
104
A
LEU
105
n
106
LEU
105
A
SER
106
n
107
SER
106
A
VAL
107
n
108
VAL
107
A
LEU
108
n
109
LEU
108
A
ALA
109
n
110
ALA
109
A
MET
0
n
1
MET
0
B
LEU
1
n
2
LEU
1
B
LYS
2
n
3
LYS
2
B
ILE
3
n
4
ILE
3
B
GLN
4
n
5
GLN
4
B
ALA
5
n
6
ALA
5
B
TYR
6
n
7
TYR
6
B
PHE
7
n
8
PHE
7
B
ASN
8
n
9
ASN
8
B
GLU
9
n
10
GLU
9
B
THR
10
n
11
THR
10
B
ALA
11
n
12
ALA
11
B
ASP
12
n
13
ASP
12
B
LEU
13
n
14
LEU
13
B
PRO
14
n
15
PRO
14
B
CYS
15
n
16
CYS
15
B
GLN
16
n
17
GLN
16
B
PHE
17
n
18
PHE
17
B
ALA
18
n
19
ALA
18
B
ASN
19
n
20
ASN
19
B
SER
20
n
21
SER
20
B
GLN
21
n
22
GLN
21
B
ASN
22
n
23
ASN
22
B
GLN
23
n
24
GLN
23
B
SER
24
n
25
SER
24
B
LEU
25
n
26
LEU
25
B
SER
26
n
27
SER
26
B
GLU
27
n
28
GLU
27
B
LEU
28
n
29
LEU
28
B
VAL
29
n
30
VAL
29
B
VAL
30
n
31
VAL
30
B
PHE
31
n
32
PHE
31
B
TRP
32
n
33
TRP
32
B
GLN
33
n
34
GLN
33
B
ASP
34
n
35
ASP
34
B
GLN
35
n
36
GLN
35
B
GLU
36
n
37
GLU
36
B
ASN
37
n
38
ASN
37
B
LEU
38
n
39
LEU
38
B
VAL
39
n
40
VAL
39
B
LEU
40
n
41
LEU
40
B
ASN
41
n
42
ASN
41
B
GLU
42
n
43
GLU
42
B
VAL
43
n
44
VAL
43
B
TYR
44
n
45
TYR
44
B
LEU
45
n
46
LEU
45
B
GLY
46
n
47
GLY
46
B
LYS
47
n
48
LYS
47
B
GLU
48
n
49
GLU
48
B
LYS
49
n
50
LYS
49
B
PHE
50
n
51
PHE
50
B
ASP
51
n
52
ASP
51
B
SER
52
n
53
SER
52
B
VAL
53
n
54
VAL
53
B
HIS
54
n
55
HIS
54
B
SER
55
n
56
SER
55
B
LYS
56
n
57
LYS
56
B
TYR
57
n
58
TYR
57
B
MET
58
n
59
MET
58
B
GLY
59
n
60
GLY
59
B
ARG
60
n
61
ARG
60
B
THR
61
n
62
THR
61
B
SER
62
n
63
SER
62
B
PHE
63
n
64
PHE
63
B
ASP
64
n
65
ASP
64
B
SER
65
n
66
SER
65
B
ASP
66
n
67
ASP
66
B
SER
67
n
68
SER
67
B
TRP
68
n
69
TRP
68
B
THR
69
n
70
THR
69
B
LEU
70
n
71
LEU
70
B
ARG
71
n
72
ARG
71
B
LEU
72
n
73
LEU
72
B
HIS
73
n
74
HIS
73
B
ASN
74
n
75
ASN
74
B
LEU
75
n
76
LEU
75
B
GLN
76
n
77
GLN
76
B
ILE
77
n
78
ILE
77
B
LYS
78
n
79
LYS
78
B
ASP
79
n
80
ASP
79
B
LYS
80
n
81
LYS
80
B
GLY
81
n
82
GLY
81
B
LEU
82
n
83
LEU
82
B
TYR
83
n
84
TYR
83
B
GLN
84
n
85
GLN
84
B
CYS
85
n
86
CYS
85
B
ILE
86
n
87
ILE
86
B
ILE
87
n
88
ILE
87
B
HIS
88
n
89
HIS
88
B
HIS
89
n
90
HIS
89
B
LYS
90
n
91
LYS
90
B
LYS
91
n
92
LYS
91
B
PRO
92
n
93
PRO
92
B
THR
93
n
94
THR
93
B
GLY
94
n
95
GLY
94
B
MET
95
n
96
MET
95
B
ILE
96
n
97
ILE
96
B
ARG
97
n
98
ARG
97
B
ILE
98
n
99
ILE
98
B
HIS
99
n
100
HIS
99
B
GLN
100
n
101
GLN
100
B
MET
101
n
102
MET
101
B
ASN
102
n
103
ASN
102
B
SER
103
n
104
SER
103
B
GLU
104
n
105
GLU
104
B
LEU
105
n
106
LEU
105
B
SER
106
n
107
SER
106
B
VAL
107
n
108
VAL
107
B
LEU
108
n
109
LEU
108
B
ALA
109
n
110
ALA
109
B
author_defined_assembly
1
monomeric
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
ILE
3
A
N
ILE
4
A
O
GLU
104
A
O
GLU
105
A
O
ILE
96
A
O
ILE
97
A
N
HIS
89
A
N
HIS
90
A
O
ILE
86
A
O
ILE
87
A
N
PHE
31
A
N
PHE
32
A
N
TRP
32
A
N
TRP
33
A
O
LEU
40
A
O
LEU
41
A
N
TYR
44
A
N
TYR
45
A
O
LYS
47
A
O
LYS
48
A
N
LEU
13
A
N
LEU
14
A
O
LEU
70
A
O
LEU
71
A
O
THR
69
A
O
THR
70
A
N
ASP
64
A
N
ASP
65
B
N
LEU
1
B
N
LEU
2
B
O
GLU
104
B
O
GLU
105
B
O
MET
101
B
O
MET
102
B
N
CYS
85
B
N
CYS
86
B
O
ILE
86
B
O
ILE
87
B
N
PHE
31
B
N
PHE
32
B
N
TRP
32
B
N
TRP
33
B
O
LEU
40
B
O
LEU
41
B
N
GLU
42
B
N
GLU
43
B
O
LYS
49
B
O
LYS
50
B
N
LEU
13
B
N
LEU
14
B
O
LEU
70
B
O
LEU
71
B
O
ARG
71
B
O
ARG
72
B
N
SER
62
B
N
SER
63
1
A
GLU
9
-107.59
-152.84
1
A
SER
62
-162.35
119.88
1
A
THR
93
-59.95
-87.84
1
B
GLU
9
-119.28
-145.92
1
B
PRO
92
-35.69
-36.83
1
B
HIS
99
-176.67
144.30
protein_rep.param
protein.top
carbohydrate.param
carbohydrate.top
49.42
21.94
3.20
9.98
0.00
0.00
-3.55
0.00
-6.43
0.278
0.011
0.214
0.258
0.252
2.70
19.83
629
5842
10.8
95.6
1.00
1.00
RANDOM
1
THROUGHOUT
2
MAD
Engh & Huber
CNS bulk solvent model used
18.2567
0.37304
isotropic
0.41
0.30
5.00
0.42
0.27
2.70
2.70
19.83
0
1804
0
0
1804
0.008
1.4
26.8
0.63
1.53
1.50
2.55
2.00
2.55
2.00
3.67
2.50
0.236
0.032
0.237
2.80
53
491
599
544
10
8.8
90.8
0.234
0.028
0.236
2.91
70
476
595
546
10
11.8
91.8
0.239
0.028
0.243
3.04
71
486
597
557
10
11.9
93.3
0.219
0.027
0.221
3.20
65
509
597
574
10
10.9
96.0
0.229
0.032
0.23
3.40
52
530
603
582
10
8.6
96.4
0.224
0.027
0.219
3.66
71
517
608
588
10
11.7
96.7
0.218
0.027
0.213
4.03
65
522
604
587
10
10.8
97.2
0.193
0.025
0.185
4.60
58
547
615
605
10
9.4
98.4
0.204
0.027
0.21
5.77
59
559
637
618
10
9.3
97.0
0.2
0.025
0.203
19.83
65
576
664
641
10
9.8
96.5
31.2
2.70
19.83
1NCN
20
0
23
0
21
0
5843
5843
1489970.80
41.080000
0.0
0.0
1
95.5
2.7
2.8
90.8
refinement
Axel T. Brunger
axel.brunger@yale.edu
1998
Fortran
CNS
package
1.0
data reduction
DENZO
data scaling
SCALEPACK
phasing
SOLVE
T lymphocyte activation antigen CD86
the receptor-binding domain of human B7-2
1
N
N
1
N
N
A
SER
24
A
SER
25
HELX_P
A
SER
26
A
SER
27
5
1
3
A
GLN
76
A
GLN
77
HELX_P
A
LYS
80
A
LYS
81
5
2
5
B
SER
24
B
SER
25
HELX_P
B
SER
26
B
SER
27
5
3
3
B
GLN
76
B
GLN
77
HELX_P
B
LYS
80
B
LYS
81
5
4
5
disulf
2.016
A
CYS
15
A
SG
CYS
16
1_555
A
CYS
85
A
SG
CYS
86
1_555
disulf
2.035
B
CYS
15
B
SG
CYS
16
1_555
B
CYS
85
B
SG
CYS
86
1_555
IMMUNE SYSTEM
Ig V, beta strands, IMMUNE SYSTEM
CD86_HUMAN
UNP
1
26
P42081
LKIQAYFNETADLPCQFANSQNQSLSELVVFWQDQENLVLNEVYLGKEKFDSVHSKYMGRTSFDSDSWTLRLHNLQIKDK
GLYQCIIHHKKPTGMIRIHQMNSELSVLA
26
134
1NCN
1
109
P42081
A
1
2
110
26
134
1NCN
1
109
P42081
B
1
2
110
1
INITIATING METHIONINE
MET
0
1NCN
A
P42081
UNP
1
2
INITIATING METHIONINE
MET
0
1NCN
B
P42081
UNP
1
6
3
6
3
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
LEU
1
A
LEU
2
A
TYR
6
A
TYR
7
A
MET
95
A
MET
96
A
LEU
108
A
LEU
109
A
GLY
81
A
GLY
82
A
LYS
90
A
LYS
91
A
LEU
28
A
LEU
29
A
ASP
34
A
ASP
35
A
VAL
39
A
VAL
40
A
TYR
44
A
TYR
45
A
LYS
47
A
LYS
48
A
GLU
48
A
GLU
49
A
ALA
11
A
ALA
12
A
PRO
14
A
PRO
15
A
THR
69
A
THR
70
A
LEU
72
A
LEU
73
A
THR
61
A
THR
62
A
ASP
64
A
ASP
65
B
LEU
1
B
LEU
2
B
TYR
6
B
TYR
7
B
GLY
94
B
GLY
95
B
LEU
108
B
LEU
109
B
GLY
81
B
GLY
82
B
LYS
91
B
LYS
92
B
LEU
28
B
LEU
29
B
ASP
34
B
ASP
35
B
VAL
39
B
VAL
40
B
TYR
44
B
TYR
45
B
LYS
47
B
LYS
48
B
LYS
49
B
LYS
50
B
ALA
11
B
ALA
12
B
PRO
14
B
PRO
15
B
THR
69
B
THR
70
B
LEU
72
B
LEU
73
B
THR
61
B
THR
62
B
ASP
64
B
ASP
65
18
P 21 21 2